Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Grimbert

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2022
Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2- Recovered Dialysis PatientsPhilippe Attias, Imane Azzaoui, Khalil El Karoui, et al.
Medicine|November 14, 2009
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infectionMarie Matignon, Patrice Cacoub, Magali Colombat, et al.
Clinical Kidney Journal|August 4, 2021
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipientsKarim El Sakhawi, Giovanna Melica, Anne Scemla, et al.
Kidney International|May 26, 2026
Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor accessCédric Usureau, Jérémy Siemowski, Dany Anglicheau, et al.
Radiology|December 12, 2023
Glomerular Filtration Rate Measured Based on Iomeprol Clearance Assessed at CT Urography in Living Kidney Donor CandidatesThomas Stehlé, Félix Wei, Séverine Brabant, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2015
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell DiseasePablo Bartolucci, Anoosha Habibi, Thomas Stehlé, et al.
International Journal of Cancer|August 30, 2018
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinomaBenoit Rousseau, Aude Guillemin, Christophe Duvoux, et al.
British Journal of Haematology|June 16, 2021
Impact of pre-eclampsia on renal outcome in sickle cell disease patientsIdris Boudhabhay, Emmanuelle Boutin, Pablo Bartolucci, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGSMarianne Delville, Emilie Baye, Antoine Durrbach, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2022
Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2- Recovered Dialysis PatientsPhilippe Attias, Imane Azzaoui, Khalil El Karoui, et al.
Medicine|November 14, 2009
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infectionMarie Matignon, Patrice Cacoub, Magali Colombat, et al.
Clinical Kidney Journal|August 4, 2021
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipientsKarim El Sakhawi, Giovanna Melica, Anne Scemla, et al.
Kidney International|May 26, 2026
Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor accessCédric Usureau, Jérémy Siemowski, Dany Anglicheau, et al.
Radiology|December 12, 2023
Glomerular Filtration Rate Measured Based on Iomeprol Clearance Assessed at CT Urography in Living Kidney Donor CandidatesThomas Stehlé, Félix Wei, Séverine Brabant, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2015
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell DiseasePablo Bartolucci, Anoosha Habibi, Thomas Stehlé, et al.
International Journal of Cancer|August 30, 2018
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinomaBenoit Rousseau, Aude Guillemin, Christophe Duvoux, et al.
British Journal of Haematology|June 16, 2021
Impact of pre-eclampsia on renal outcome in sickle cell disease patientsIdris Boudhabhay, Emmanuelle Boutin, Pablo Bartolucci, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGSMarianne Delville, Emilie Baye, Antoine Durrbach, et al.
Pageof 13